Description

4-Morpholinebutanoic acid, alpha-(((methyl((2-(1-methylethyl)-4-thiazolyl)methyl)amino)carbonyl)amino)-, ethyl ester, ethanedioate, (alphaS)- is a high-purity synthetic compound with the molecular formula C₂₁H₃₄N₄O₈S. This specialized chemical features a complex structure combining morpholine, thiazole, and oxalate moieties, making it valuable for advanced research applications. The compound is provided as an oxalic acid salt to enhance stability and solubility. With a CAS number of 1247119-36-3, it is rigorously characterized by HPLC, NMR, and mass spectrometry to ensure >95% purity. Ideal for medicinal chemistry, drug discovery, and biochemical studies, this product is available in convenient quantities with strict quality control.

Properties

• CAS Number: 1247119-36-3
• Complexity: 574
• IUPAC Name: ethyl (2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-4-morpholino-butanoate;oxalic acid
• InChI: InChI=1S/C19H32N4O4S.C2H2O4/c1-5-27-18(24)16(6-7-23-8-10-26-11-9-23)21-19(25)22(4)12-15-13-28-17(20-15)14(2)3;3-1(4)2(5)6/h13-14,16H,5-12H2,1-4H3,(H,21,25);(H,3,4)(H,5,6)/t16-;/m0./s1
• InChI Key: QZLDJULECASEHV-NTISSMGPSA-N
• Exact Mass: 502.20973523
• Molecular Formula: C21H34N4O8S
• Molecular Weight: 502.6
• SMILES: CCOC(=O)[C@H](CCN1CCOCC1)NC(=O)N(C)CC2=CSC(=N2)C(C)C.C(=O)(C(=O)O)O
• Topological: 187
• Monoisotopic Mass: 502.20973523
• Synonyms: 1247119-36-3, EC 931-074-0, 4-Morpholinebutanoic acid, alpha-(((methyl((2-(1-methylethyl)-4-thiazolyl)methyl)amino)carbonyl)amino)-, ethyl ester, ethanedioate, (alphaS)-, 4-Morpholinebutanoic acid, alpha-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-, ethyl ester, ethanedioate (1:1), (alphaS)-, 4-Morpholinebutanoic acid, alpha-(((methyl((2-(1-methylethyl)-4-thiazolyl)methyl)amino)carbonyl)amino)-, ethyl ester, ethanedioate (1:1), (alphaS)-, 4-Morpholinebutanoic acid, alpha-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-, ethyl ester, ethanedioate, (alphaS)-, 931-074-0, (S)-ethyl 2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanoate oxalate, ethyl (2S)-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]-4-morpholin-4-ylbutanoate;oxalic acid, Ethyl (2S)-2-[[[2-(1-Methylethyl)thiazol-4-yl]methyl(methyl)carbamoyl]amino]-4-morpholinobutanoate Oxalate, (S)-ethyl2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanoateoxalate, SCHEMBL18006704, C21H34N4O8S, AKOS030527997, (S)-ethyl-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanoate oxalate, DS-19508, DB-248063, CS-0162098, C71977, 4-Morpholinebutanoic acid, |A-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-, ethyl ester, ethanedioate (1:1), (|AS)-, 4-Morpholinebutanoic acid, a-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-, ethyl ester, ethanedioate (1:1), (aS)-; Ethyl (2S)-2-[[[2-(1-Methylethyl)thiazol-4-yl]methyl(methyl)carbamoyl]amino]-4-morpholinobutanoate Oxalate

Application

This compound serves as a key intermediate in the synthesis of novel pharmaceuticals targeting enzyme inhibition and receptor modulation. Researchers utilize its unique structure for developing thiazole-containing bioactive molecules in medicinal chemistry. The morpholine and carbamoyl functional groups make it particularly useful for studying drug-receptor interactions and pharmacokinetic properties.

Safety and Hazards

GHS Hazard Statements

• Not Classified
• Reported as not meeting GHS hazard criteria by 3 of 3 companies. For more detailed information, please visit ECHA C&L website.

Hazard Classes and Categories

• Not Classified

If you are interested or have any questions, please contact us at support@atomfair.com

Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.